Aptamer Group PLC (AIM:APTA)

Market Cap	19.87M +169.6%
Revenue (ttm)	1.38M +13.4%
Net Income	-2.46M
EPS	-0.00
Shares Out	3.46B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,062,118
Open	0.5725
Previous Close	0.5750
Day's Range	0.5500 - 0.6000
52-Week Range	0.3000 - 1.5700
Beta	0.92
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 30, 2026

About Aptamer Group

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and b...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 30
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: APTA

Financial Performance

In fiscal year 2025, Aptamer Group's revenue was 1.20 million, an increase of 39.88% compared to the previous year's 860,000. Losses were -2.42 million, -18.05% less than in 2024.